Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-27 | 2019-08-21 | 87684 |
| RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2019-07-02 | 2019-07-16 | 88167 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-08-06 | 2019-11-19 | 90935 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92180 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-10 | 92198 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92229 |
| TEVA-LATANOPROST | 0.05MG | SOLUTION | Resolved | 2019-09-05 | 2020-07-10 | 93159 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-09-12 | 2019-11-22 | 93650 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-09-26 | 2019-11-14 | 94840 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-10-10 | 95373 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-10-10 | 95378 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-11-01 | 95381 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Resolved | 2019-10-24 | 2020-05-14 | 97147 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-07 | 2020-02-21 | 98179 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-07 | 2020-01-27 | 98185 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2019-11-07 | 2020-05-29 | 98188 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-11-21 | 2020-01-09 | 99441 |
| VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-28 | 2020-06-25 | 99955 |
| TEVA-COMBO STERINEBS | 0.5MG 2.5MG | SOLUTION | Resolved | 2019-12-19 | 2020-09-03 | 101702 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2020-01-09 | 2020-02-21 | 102893 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |